The Scientist - Home

The changes would further restrict which scientific findings can be used in drafting regulations.

Criticism of the paper first surfaced in 1994, and its author was accused of scientific misconduct.

Merck’s Ervebo gets its first regulatory greenlight. A decision from the US Food and Drug Administration is expected in the next few months.

The chemical was found in all 29 lung fluid samples tested.

TAK-003 appears to avoid the safety issues seen with an existing vaccine, but experts say a longer evaluation is needed.

After a series of appeals from the university, Missouri courts have ruled for the third time that students have collective bargaining rights.

Dropping the transcription factor from the four so-called Yamanaka factors reduces the efficiency of inducing the production of stem cells, but the resulting cells are of greater quality.

The 12-million-year-old bones of a previously unknown species named Danuvius guggenmosi challenge the prevailing view about when and where our ancestors first started walking upright.

Voters approved a measure to double the state’s Cancer Prevention & Research Institute of Texas.

Colorectal tumor cells limit their DNA repair in response to a targeted therapy, giving them a greater chance to develop resistance to the drug.

Cardiomyocytes made from iPSCs aboard the International Space Station had upregulated mitochondrial functioning.

A study identifies five women who have a functioning sense of smell despite an apparent lack of olfactory bulbs—the region of the brain that processes odors.